Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Finnzymes

1986 FOUNDED
M&A STATUS
81-90 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Manufacturer of scientific instruments for molecular biology analysis designed to improve the performance of enzymes. The company's focus lies on the development of comprehensive applications for high-performance polymerase chain reaction (PCR), reverse transcription-PCR (RT-PCR) and real-time quantitative PCR (qPCR), enabling healthcare industry to quickly and reproducibly amplify and quantify particular DNA sequences, used in a variety of applications, including basic genomic research, genetic testing, forensics and food testing.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Acquirer
Primary Office
  • Keilaranta 16 A
  • 02150 Espoo
  • Finland

Finnzymes Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Finnzymes‘s full profile, request access.

Request full access to PitchBook

Finnzymes Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Finnzymes‘s full profile, request access.

Request full access to PitchBook